MSCV Luciferase PGK-hygro Citations (28)
Originally described in: Lowe Lab PlasmidsUnpublished
Articles Citing MSCV Luciferase PGK-hygro
| Articles |
|---|
| Epigenetic modulation to enable antigen-specific T-cell therapy of colorectal cancer. Chou J, Voong LN, Mortales CL, Towlerton AM, Pollack SM, Chen X, Yee C, Robbins PF, Warren EH. J Immunother. 2012 Feb-Mar;35(2):131-41. doi: 10.1097/CJI.0b013e31824300c7. PubMed |
| Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progression. Lopez-Lago MA, Posner S, Thodima VJ, Molina AM, Motzer RJ, Chaganti RS. Oncogene. 2013 Apr 4;32(14):1752-60. doi: 10.1038/onc.2012.201. Epub 2012 Jun 4. PubMed |
| CD8+ T-cell clones specific for the 5T4 antigen target renal cell carcinoma tumor-initiating cells in a murine xenograft model. Tykodi SS, Satoh S, Deming JD, Chou J, Harrop R, Warren EH. J Immunother. 2012 Sep;35(7):523-33. doi: 10.1097/CJI.0b013e318261d630. PubMed |
| Establishing isogenic inducible cell lines using founder reporter lines and recombinase-mediated cassette exchange. Guan B, Magomi T, Wang TL, Shih IeM. Biotechniques. 2013 Nov;55(5):233-42. doi: 10.2144/000114098. PubMed |
| Combination of immortalization and inducible death strategies to generate a human mesenchymal stromal cell line with controlled survival. Bourgine P, Le Magnen C, Pigeot S, Geurts J, Scherberich A, Martin I. Stem Cell Res. 2014 Mar;12(2):584-98. doi: 10.1016/j.scr.2013.12.006. Epub 2013 Dec 27. PubMed |
| Lysyl oxidase family activity promotes resistance of pancreatic ductal adenocarcinoma to chemotherapy by limiting the intratumoral anticancer drug distribution. Le Calve B, Griveau A, Vindrieux D, Marechal R, Wiel C, Svrcek M, Gout J, Azzi L, Payen L, Cros J, de la Fouchardiere C, Dubus P, Guitton J, Bartholin L, Bachet JB, Bernard D. Oncotarget. 2016 Apr 1. doi: 10.18632/oncotarget.8527. PubMed |
| Non-cell-autonomous Effects of Autophagy Inhibition in Tumor Cells Promote Growth of Drug-resistant Cells. Thorburn J, Staskiewicz L, Goodall ML, Dimberg L, Frankel AE, Ford HL, Thorburn A. Mol Pharmacol. 2017 Jan;91(1):58-64. Epub 2016 Nov 9. PubMed |
| Survival of pancreatic cancer cells lacking KRAS function. Muzumdar MD, Chen PY, Dorans KJ, Chung KM, Bhutkar A, Hong E, Noll EM, Sprick MR, Trumpp A, Jacks T. Nat Commun. 2017 Oct 23;8(1):1090. doi: 10.1038/s41467-017-00942-5. PubMed |
| Early detection of pancreatic cancer in mouse models using a novel antibody, TAB004. Wu ST, Williams CD, Grover PA, Moore LJ, Mukherjee P. PLoS One. 2018 Feb 20;13(2):e0193260. doi: 10.1371/journal.pone.0193260. eCollection 2018. PubMed |
| Treatment of pancreatic ductal adenocarcinoma with tumor antigen specific-targeted delivery of paclitaxel loaded PLGA nanoparticles. Wu ST, Fowler AJ, Garmon CB, Fessler AB, Ogle JD, Grover KR, Allen BC, Williams CD, Zhou R, Yazdanifar M, Ogle CA, Mukherjee P. BMC Cancer. 2018 Apr 23;18(1):457. doi: 10.1186/s12885-018-4393-7. PubMed |
| Interleukin-17 promotes metastasis in an immunocompetent orthotopic mouse model of prostate cancer. Cunningham D, Zhang Q, Liu S, Parajuli KR, Nie Q, Ma L, Zhang A, Chen Z, You Z. Am J Clin Exp Urol. 2018 Jun 15;6(3):114-122. eCollection 2018. PubMed |
| In vivo reprogramming of wound-resident cells generates skin epithelial tissue. Kurita M, Araoka T, Hishida T, O'Keefe DD, Takahashi Y, Sakamoto A, Sakurai M, Suzuki K, Wu J, Yamamoto M, Hernandez-Benitez R, Ocampo A, Reddy P, Shokhirev MN, Magistretti P, Nunez Delicado E, Eto H, Harii K, Izpisua Belmonte JC. Nature. 2018 Sep;561(7722):243-247. doi: 10.1038/s41586-018-0477-4. Epub 2018 Sep 5. PubMed |
| Inhibition of MYC attenuates tumor cell self-renewal and promotes senescence in SMARCB1-deficient Group 2 atypical teratoid rhabdoid tumors to suppress tumor growth in vivo. Alimova I, Pierce A, Danis E, Donson A, Birks DK, Griesinger A, Foreman NK, Santi M, Soucek L, Venkataraman S, Vibhakar R. Int J Cancer. 2019 Apr 15;144(8):1983-1995. doi: 10.1002/ijc.31873. Epub 2019 Jan 10. PubMed |
| Interplay between transcription regulators RUNX1 and FUBP1 activates an enhancer of the oncogene c-KIT and amplifies cell proliferation. Debaize L, Jakobczyk H, Avner S, Gaudichon J, Rio AG, Serandour AA, Dorsheimer L, Chalmel F, Carroll JS, Zornig M, Rieger MA, Delalande O, Salbert G, Galibert MD, Gandemer V, Troadec MB. Nucleic Acids Res. 2018 Nov 30;46(21):11214-11228. doi: 10.1093/nar/gky756. PubMed |
| A microfluidic assay for the quantification of the metastatic propensity of breast cancer specimens. Yankaskas CL, Thompson KN, Paul CD, Vitolo MI, Mistriotis P, Mahendra A, Bajpai VK, Shea DJ, Manto KM, Chai AC, Varadarajan N, Kontrogianni-Konstantopoulos A, Martin SS, Konstantopoulos K. Nat Biomed Eng. 2019 Jun;3(6):452-465. doi: 10.1038/s41551-019-0400-9. Epub 2019 May 6. PubMed |
| Combining the Specific Anti-MUC1 Antibody TAB004 and Lip-MSA-IL-2 Limits Pancreatic Cancer Progression in Immune Competent Murine Models of Pancreatic Ductal Adenocarcinoma. Dreau D, Moore LJ, Wu M, Roy LD, Dillion L, Porter T, Puri R, Momin N, Wittrup KD, Mukherjee P. Front Oncol. 2019 Apr 30;9:330. doi: 10.3389/fonc.2019.00330. eCollection 2019. PubMed |
| Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors. Dangaj D, Bruand M, Grimm AJ, Ronet C, Barras D, Duttagupta PA, Lanitis E, Duraiswamy J, Tanyi JL, Benencia F, Conejo-Garcia J, Ramay HR, Montone KT, Powell DJ Jr, Gimotty PA, Facciabene A, Jackson DG, Weber JS, Rodig SJ, Hodi SF, Kandalaft LE, Irving M, Zhang L, Foukas P, Rusakiewicz S, Delorenzi M, Coukos G. Cancer Cell. 2019 Jun 10;35(6):885-900.e10. doi: 10.1016/j.ccell.2019.05.004. PubMed |
| The FlpTRAP system for purification of specific, endogenous chromatin regions. Jensen IS, Yuan J, He J, Lin L, Sander B, Golas MM. Anal Biochem. 2019 Dec 15;587:113418. doi: 10.1016/j.ab.2019.113418. Epub 2019 Sep 11. PubMed |
| ASCL1-regulated DARPP-32 and t-DARPP stimulate small cell lung cancer growth and neuroendocrine tumour cell proliferation. Alam SK, Wang L, Ren Y, Hernandez CE, Kosari F, Roden AC, Yang R, Hoeppner LH. Br J Cancer. 2020 Jun 5. pii: 10.1038/s41416-020-0923-6. doi: 10.1038/s41416-020-0923-6. PubMed |
Akaluc bioluminescence offers superior sensitivity to track in vivo glioma expansion.
Bozec D, Sattiraju A, Bouras A, Jesu Raj JG, Rivera D, Huang Y, Junqueira Alves C, Tejero R, Tsankova NM, Zou H, Hadjipanayis C, Friedel RH.
Neurooncol Adv. 2020 Oct 10;2(1):vdaa134. doi: 10.1093/noajnl/vdaa134. eCollection 2020 Jan-Dec.
PubMed
Associated Plasmids |
| Microtubule disruption reduces metastasis more effectively than primary tumor growth. Thompson KN, Ju JA, Ory EC, Pratt SJP, Lee RM, Mathias TJ, Chang KT, Lee CJ, Goloubeva OG, Bailey PC, Chakrabarti KR, Jewell CM, Vitolo MI, Martin SS. Breast Cancer Res. 2022 Feb 14;24(1):13. doi: 10.1186/s13058-022-01506-2. PubMed |
| Synthetic introns enable splicing factor mutation-dependent targeting of cancer cells. North K, Benbarche S, Liu B, Pangallo J, Chen S, Stahl M, Bewersdorf JP, Stanley RF, Erickson C, Cho H, Pineda JMB, Thomas JD, Polaski JT, Belleville AE, Gabel AM, Udy DB, Humbert O, Kiem HP, Abdel-Wahab O, Bradley RK. Nat Biotechnol. 2022 Jul;40(7):1103-1113. doi: 10.1038/s41587-022-01224-2. Epub 2022 Mar 3. PubMed |
| Reciprocal regulation of Daxx and PIK3CA promotes colorectal cancer cell growth. Huang YS, Wu CC, Chang CC, Huang SF, Kuo HY, Shih HM. Cell Mol Life Sci. 2022 Jun 19;79(7):367. doi: 10.1007/s00018-022-04399-8. PubMed |
| Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis. He D, Feng H, Sundberg B, Yang J, Powers J, Christian AH, Wilkinson JE, Monnin C, Avizonis D, Thomas CJ, Friedman RA, Kluger MD, Hollingsworth MA, Grandgenett PM, Klute KA, Toste FD, Chang CJ, Chio IIC. Mol Cell. 2022 Aug 18;82(16):3045-3060.e11. doi: 10.1016/j.molcel.2022.06.005. Epub 2022 Jun 24. PubMed |
| Novel antimyeloma therapeutic option with inhibition of the HDAC1-IRF4 axis and PIM kinase. Harada T, Ohguchi H, Oda A, Nakao M, Teramachi J, Hiasa M, Sumitani R, Oura M, Sogabe K, Maruhashi T, Takahashi M, Fujii S, Nakamura S, Miki H, Kagawa K, Ozaki S, Sano S, Hideshima T, Abe M. Blood Adv. 2023 Mar 28;7(6):1019-1032. doi: 10.1182/bloodadvances.2022007155. PubMed |
| Hypoxia regulates CD9 expression and dissemination of B lymphoblasts. Rouger-Gaudichon J, Cousin E, Jakobczyk H, Debaize L, Rio AG, Forestier A, Arnaud MP, Villacreces A, Praloran V, Jacamo R, Galibert MD, Troadec MB, Gandemer V. Leuk Res. 2022 Dec;123:106964. doi: 10.1016/j.leukres.2022.106964. Epub 2022 Sep 28. PubMed |
| CNK2 promotes cancer cell motility by mediating ARF6 activation downstream of AXL signalling. Serwe G, Kachaner D, Gagnon J, Plutoni C, Lajoie D, Durame E, Sahmi M, Garrido D, Lefrancois M, Arseneault G, Saba-El-Leil MK, Meloche S, Emery G, Therrien M. Nat Commun. 2023 Jun 15;14(1):3560. doi: 10.1038/s41467-023-39281-z. PubMed |
| Differential histone acetylation and super-enhancer regulation underlie melanoma cell dedifferentiation. Mendelson K, Martin TC, Nguyen CB, Hsu M, Xu J, Lang C, Dummer R, Saenger Y, Messina JL, Sondak VK, Desman G, Hasson D, Bernstein E, Parsons RE, Celebi JT. JCI Insight. 2024 Feb 6;9(6):e166611. doi: 10.1172/jci.insight.166611. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.